Lai Wang, President, Global Head of R&D at BeOne Medicines Ltd. (ONC), sold 756 shares at $261.00 ($197K) on 2026-06-11, disclosed to the SEC on 2026-06-15.
Open-market sale of $197k ONC by President, Global Head of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ONC | SELL | 2026-06-10 | $368K | — | Filing → |
| ONC | SELL | 2025-09-11 | $1.8M | — | Filing → |
| ONC | SELL | 2025-07-31 | $1.6M | — | Filing → |